Posted by Chana Mayefsky on August 9, 2011 06:00 PM
Apple edges past Exxon to become the biggest public company in the world (while AOL has a bad day); and stops Samsung's Galaxy Tab in Europe with legal ruling.
Barney's NY hires former French Vogue editor Carine Roitfeld as model and consultant.
Disney profits from sales of Cars 2 and Marvel merchandise, and ESPN revenues.
Facebook rolls out mobile Messenger feature.
Ford manages expectations of eager Focus electric car buyers.
Hero MotorCorp unveils brand identity.
J&J reaches agreement with U.S. on Risperdal charge.Continue reading...
Posted by Sheila Shayon on August 5, 2011 10:57 AM
Pfizer was compelled to take down its Facebook page after being hacked July 19th by U.K. hackers, The Script Kiddies, who claimed responsibility for the social misdeed on Twitter. The group's grievance, apparently, is that (in their words) the pharma giant is “A Corrupt Corporate American Company guilty of cutting corners and killing people.” Such are the charming times we live in.
A screenshot of the hacked posts shows the Pfizer logo smeared in red (above) and information about Pfizer's $2.3 billion settlement of a U.S. investigation of its drug-marketing practices in 2009.
Hackers have been targeting government agencies and major corporations in the past several months — if you haven't read about Operation Shady RAT, Vanity Fair has a good backgrounder — so the fear is this attack is just the tip of the online iceberg for Big Pharma, an industry that was already tiptoeing (read: reticent) to embrace social media.Continue reading...
Posted by Shirley Brady on August 3, 2011 06:00 PM
AT&T challenges ESPN on 3DTV claims.
Audi signs on as Emmys sponsor.
Budweiser rebrands its can.
Burger King, Wendy's, Subway, Taco Bell, Carl's Jr. lead US fast food brands expanding in Russia.
Coca-Cola tests "FaceLook" facial recognition Facebook app in Israel.
Dunkin' Brands quarterly profits slip.
Facebook marketing director (and sister-of-Mark) Randi Zuckerberg quits to launch a start-up.
Google accuses Apple, Oracle and Microsoft of "patent bullying."Continue reading...
Posted by Dale Buss on June 13, 2011 09:00 AM
Apple store employee moves to unionize.
Chipotle expansion plans hit by rising costs.
Citi defends delay in disclosing hacking.
Dell gives precedence to Chinese market for tablet roll-out.
Dole blitzes US cities to pump up banana sales.
Edmunds.com to launch Groupon-type channel for cars.
Ford is ordered to pay $2 billion to dealers in old pricing dispute.Continue reading...
Posted by Dale Buss on June 9, 2011 09:00 AM
BP now says Rosneft deal is really dead.
Citigroup confirms data breach.
Exxon unveils major oil and gas find in the Gulf of Mexico.
Financial Times circumvents Apple sales system with app.
L’Oreal heiress saga continues.
Nokia sees departure of chief technology officer.Continue reading...
Posted by Dale Buss on June 8, 2011 09:00 AM
Asos sets sights on male fashion lovers.
Atari plots its comeback.
Au Bon Pain unveils new redesign.
Avaya plans to go public again.
Benetton readies image overhaul.
Blue Shield of California will cap earnings.
Borders finds another potential bidder.Continue reading...
Posted by Shirley Brady on June 1, 2011 06:00 PM
The Daily Mail repeats "wild rumors" that P&G is planning to bid for Unilever.
Australia reverses ban on gay safe-sex ads.
Eastman Kodak launches recyling program.
Google launches +1 button as Twitter introduces one-click follow button.
Groupon expands real-time deals to New York and San Francisco as Google Offers goes live in Portland, OR.
Pfizer scores with soccer-themed web game in the UK.
Shaquille O'Neal announced his retirement from the NBA on Twitter, using video from new startup Tout.Continue reading...
Posted by Mark J. Miller on May 25, 2011 10:00 AM
Sick of shelling out big bucks for your Lipitor and other brand-name drugs? Well, it doesn’t appear that you’ll need to do it for a whole lot longer. But you will have to memorize the actual medical name of your medicine rather than such catchy brand names as Zyprexa, Plavix, and Singulair.
They're just a few of the brand-name drugs that will go on the market in a cheaper, generic form in the next two years.
Why? Because the patents on these and other brands will run out and allow for other companies to offer those generics at lower prices since the patent royalties and marketing costs will disappear, creating a boon for consumers and a headache for Big Pharma.Continue reading...